Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

Added 241 days ago (19.01.2021)
Authors: Karzai, F., Walker, S. M., Wilkinson, S., Madan, R. A., Shih, J. H., Merino, M. J., Harmon, S. A., VanderWeele, D. J., Cordes, L. M., Carrabba, N. V., Bright, J. R., Terrigino, N. T., Chun, G., Bilusic, M., Couvillon, A., Hankin, A., Williams, M. N., Lis, R. T., Ye, H., Choyke, P. L., Gulley, J. L., Sowalsky, A. G., Turkbey, B., Pinto, P. A., Dahut, W. L.
Read article